نتایج جستجو برای: high risk breast cancer

تعداد نتایج: 3546580  

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010
Maria M Gramatges Melinda L Telli Raymond Balise James M Ford

Telomeres cap the ends of chromosomes and are composed of a series of noncoding hexamer repeats. Telomeres protect the integrity of DNA coding sequences and are integral to the maintenance of genomic stability. Previous studies have shown an association between shortened lymphocyte telomeres and increased risk for specific cancers. However, the association between telomere length and breast can...

2012
Ava Kwong Annie TW Chu

Women who carry a mutation of BRCA1 or BRCA 2 gene have an increased lifetime risk of breast cancer as high as 50-85% (Matloff et al., 2000; Antoniou et al., 2003; King et al., 2003). The annual risk for contralateral cancer for mutated BRCA1 or BRCA2 carrier is increased by approximately 3% and the overall risk may be as high as 52% by age 70 years. Options for carriers include early and regul...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015
Hannah Arem Louise A Brinton Steven C Moore Susan M Gapstur Laurel A Habel Kenneth Johnson Laurence N Kolonel Valerie A McCormack Karin B Michels Howard D Sesso Giske Ursin Stephen K Van Den Eeden Elisabete Weiderpass Michael B Cook Charles E Matthews

The association between leisure-time physical activity (LTPA) and male breast cancer risk is unclear. In the Male Breast Cancer Pooling Project, with 449 cases and 13,855 matched controls, we used logistic regression with study stratification to generate adjusted ORs and 95% confidence intervals (CI) for LTPA tertiles and male breast cancer risk. Compared with low LTPA, medium and high LTPA wer...

Journal: :Cancer prevention research 2012
Reena S Cecchini Joseph P Costantino Jane A Cauley Walter M Cronin D Lawrence Wickerham Stephanie R Land Joel L Weissfeld Norman Wolmark

High body mass index (BMI) has been associated with an increased risk for breast cancer among postmenopausal women. However, the relationship between BMI and breast cancer risk in premenopausal women has remained unclear. Data from two large prevention trials conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) were used to explore the relationship between baseline BMI a...

Journal: :iranian red crescent medical journal 0
hanifeh mirtavoos mahyari chronic respiratory disease research center, national research institute of tuberculosis and lung disease (nritld), shahid beheshti university of medical sciences, tehran, ir iran adnan khosravi hematology and medical oncology, chronic respiratory disease research center, national research institute of tuberculosis and lung disease (nritld), shahid beheshti university of medical sciences, tehran, ir iran; hematology and medical oncology, chronic respiratory disease research center, national research institute of tuberculosis and lung disease (nritld), shahid beheshti university of medical sciences, tehran, ir iran. tel: +98-2126109946 zeinab mirtavoos mahyari tehran medical branch, islamic azad university, tehran, ir iran zahra esfahani monfared mycobacteriology research center, national research institute of tuberculosis and lung disease (nritld), shahid beheshti university of medical sciences, tehran, ir iran negin khosravi north tehran branch, azad university of tehran, tehran, ir iran

conclusions this study on a limited number of patients treated with adjutant anthracyclins-based regimens, revealed that her2/neu is not a unique strong predictor for outcome, thus according to combination of her2/neu status and other clinical factors, it is necessary to distinguish patients at high risk of recurrence. results her2/neu amplification was identified in 19 (38%) of 50 patients. no...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012
Matthew P Banegas Klaus Püschel Javiera Martínez-Gutiérrez Jennifer C Anderson Beti Thompson

BACKGROUND Breast cancer is the most frequently diagnosed malignancy among Chilean women and an increasingly significant public health threat. This study assessed the accuracy of breast cancer risk perception among underserved, Chilean women. METHODS Women aged 50 to 70 years, with no mammogram during the last 2 years, were randomly selected from a community clinic registry in Santiago, Chile...

Journal: :Journal of insurance medicine 1999
L C Hartmann D J Schaid J E Woods T P Crotty J L Myers P G Arnold P M Petty T A Sellers J L Johnson S K McDonnell M H Frost R B Jenkins

BACKGROUND Options for women at high risk for breast cancer include surveillance, chemoprevention, and prophylactic mastectomy. The data on the outcomes for surveillance and prophylactic mastectomy are incomplete. METHODS We conducted a retrospective study of all women with a family history of breast cancer who underwent bilateral prophylactic mastectomy at the Mayo Clinic between 1960 and 19...

Journal: :basic and clinical cancer research 0
omid beiki cancer research center, cancer institute of iran, tehran university of medical sciences, tehran, iran

background : migrant studies offer a unique opportunity to analyze variation in disease occurrence due to background factors. the role of environmental and lifestyle exposures are of particular interest in cancer research, and migrant studies can be considered as natural experiments in epidemiological research. large numbers of immigrants from different regions of the world and the availability...

Journal: :The oncologist 2004
Silvana Martino Joseph Costantino Michelle McNabb John Mershon Katherine Bryant Trevor Powles Roberta J Secrest

The role of estrogen in the development of breast cancer is well recognized, and the use of selective estrogen receptor modulators (SERMs) to reduce breast cancer risk continues to be evaluated. Tamoxifen is the only SERM approved for the reduction of breast cancer incidence in women at high risk. This approval was based on results from the Breast Cancer Prevention Trial. Although initial resul...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید